Gallbladder Cancer (DBCOND0028579)

Identifiers

Synonyms
Gallbladder Malignant Neoplasm / Gallbladder neoplasms malignant / Gall Bladder Cancer / Cancer of the Gallbladder / Cancer, Gall Bladder / Cancer of Gallbladder / Gall Bladder Cancers / Gallbladder cancer / Malignant neoplasm of gallbladder / Malignant tumor of gallbladder (disorder) / Gallbladder cancer NOS

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Uracil
An antineoplastic agent used in combination with tegafur to treat various cancers, including breast, prostate, and liver cancer.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05606029
A Case Series on Incidentally Detected Gallbladder MalignancyNo drug interventionsNot AvailableNot Availablecompleted
NCT05712356
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients with Advanced Solid Tumorstreatment2recruiting
NCT06631352
Outcomes and Prognostic Factors in HepatopancreatoduodenectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Typestreatment1 / 2recruiting
NCT04856761
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical ResectionNot AvailableNot Availablerecruiting
NCT00767234
Permission to Collect Blood Over Time for ResearchNo drug interventionsNot AvailableNot Availableterminated
NCT03985072
Study With Andes-1537 in Patients With Specific Types of Advanced Solid TumorNo drug interventionstreatment1completed
NCT06214572
Radiation Therapy in Unresectable Gall Bladder Cancertreatment2 / 3recruiting
NCT04426669
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineeringtreatment1 / 2recruiting
NCT05506943
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)treatment2 / 3active_not_recruiting
NCT06101277
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)No drug interventionstreatmentNot Availablerecruiting
NCT01135849
B-Receptor Signaling in CardiomyopathyNo drug interventionsNot AvailableNot Availablecompleted
NCT01875549
Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD StentNo drug interventionstreatmentNot Availablewithdrawn
NCT03668418
Xenotransplantation of Primary Cancer Samples in Zebrafish EmbryosNot AvailableNot Availableunknown_status
NCT01016639
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal CancerNo drug interventionstreatment1 / 2completed
NCT06246448
Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)No drug interventionstreatmentNot Availablerecruiting
NCT04164069
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumabprevention1active_not_recruiting
NCT00338988
Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinomatreatment2completed
NCT04561453
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00409864
Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder CancerNo drug interventionstreatmentNot Availablecompleted
NCT06189664
Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00955721
A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancertreatment1 / 2terminated
NCT04871321
Biomarker Discovery in Patients With Advanced Biliary Tract CancerNot AvailableNot Availablerecruiting
NCT00363584
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancertreatment3completed
NCT04907643
Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesNo drug interventionssupportive_careNot Availablerecruiting
NCT00423254
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.No drug interventionstreatment1completed
NCT06276153
Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01313377
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgerytreatment3completed
NCT05404347
NGS in Gallbladder Cancer and Response to TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT06223061
Global Evaluation of Cholecystectomy Knowledge and OutcomesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00919061
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapytreatment2completed
NCT03833661
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)treatment2completed
NCT02692911
Chile Biliary Longitudinal StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00658593
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancertreatment3terminated
NCT00009893
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancertreatment2completed
NCT04534309
Behavioral Weight Loss Program for Cancer Survivors in MarylandNo drug interventionspreventionNot Availablecompleted
NCT05718115
Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03111732
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)treatment2completed
NCT02659852
A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary ObstructionNo drug interventionstreatmentNot Availableunknown_status
NCT04742959
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumorstreatment1 / 2completed
NCT00660699
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancerstreatment2completed
NCT01320241
Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary StrictureNo drug interventionstreatment2completed
NCT00027534
Vaccine Therapy in Treating Patients With Advanced or Metastatic CancerNo drug interventionstreatment1completed
NCT00304135
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgerytreatment2 / 3completed
NCT00588263
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00123825
Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancertreatment2completed
NCT04104230
Quebec Pancreas Cancer StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02662348
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive Systemtreatment1unknown_status
NCT02326948
Alcohol Consumption and Gallbladder CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00003557
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancertreatment2completed
NCT00987766
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancertreatment1completed
NCT04308174
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancertreatment2active_not_recruiting
NCT00654160
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancertreatment1completed
NCT05559229
Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case ReportNo drug interventionsNot AvailableNot Availablecompleted
NCT00836992
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06061744
Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder CancerNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01308840
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancertreatment2completed
NCT00012246
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tracttreatment2terminated
NCT04383210
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumorstreatment2active_not_recruiting
NCT02778308
Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader CarcinomatreatmentNot Availablecompleted
NCT00005938
DX-8951f in Treating Patients With Biliary Cancertreatment2completed
NCT06232538
UCAD for Diagnosing Benign or Malignant Gallbladder Diseases and Follow-upNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04337333
Two-in-one Covered and Uncovered Metal StentNo drug interventionstreatmentNot Availableunknown_status
NCT02293954
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerdiagnosticNot Availableactive_not_recruiting
NCT02920554
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00350753
Avastin and Tarceva for Upper Gastrointestinal Cancerstreatment2completed
NCT05253053
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT02836847
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinomatreatment2unknown_status
NCT03210298
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)No drug interventionsNot AvailableNot Availableunknown_status
NCT00073905
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancersupportive_care2completed
NCT00266097
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancertreatment1completed
NCT00005997
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancertreatment2terminated
NCT00391183
Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.No drug interventionssupportive_care2 / 3completed
NCT00356161
HAI Via Interventionally Implanted Port Catheter SystemsNo drug interventionstreatment2unknown_status
NCT00003411
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancertreatment1completed
NCT05237193
A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-upNo drug interventionsNot AvailableNot Availableunknown_status
NCT00544193
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancertreatment1completed
NCT06134193
Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancertreatment2not_yet_recruiting
NCT03491878
Three Dimension Laparoscopic Versus Open Surgery for Gallbladder CarcinomaNo drug interventionstreatmentNot Availableunknown_status
NCT00280709
Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary ObstructionNo drug interventionstreatment4completed
NCT05896956
The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract DiseasesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00486356
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancertreatment1completed
NCT05833815
Addition of Everolimus to Standard of Care in Carcinoma Gallbladdertreatment2 / 3recruiting
NCT00489515
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderNo drug interventionsNot AvailableNot Availablecompleted
NCT00832637
Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancerstreatment2terminated
NCT04445532
Hepatobiliary Tumors Tissue Samples AcquisitionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03772132
Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaNo drug interventionstreatment2unknown_status
NCT05184400
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00753675
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancertreatment2completed
NCT03768375
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaNo drug interventionstreatment2unknown_status
NCT05596370
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00084942
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladdertreatment2completed
NCT02012699
Integrated Cancer Repository for Cancer ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT04362449
Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydrationsupportive_care2unknown_status
NCT01926236
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancerstreatment3completed
NCT04484636
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)No drug interventionsotherNot Availablerecruiting
NCT05757336
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancertreatment2recruiting
NCT00019513
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomastreatment1completed
NCT06192719
EULAT Eradicate GBCNo drug interventionsNot AvailableNot Availablerecruiting
NCT06123117
STALL vs Sole Local Wound Infiltration in Laparoscopic CholecystectomyNo drug interventionssupportive_careNot Availablerecruiting
NCT00386516
Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancertreatment2withdrawn
NCT00003296
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancertreatment2unknown_status
NCT00903396
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancersupportive_care2terminated
NCT00789958
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Ducttreatment2completed
NCT00513539
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgerytreatment3completed
NCT02489422
Programs To Support You During ChemotherapyNo drug interventionssupportive_careNot Availablecompleted
NCT01640522
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related SymptomsNo drug interventionssupportive_careNot Availablecompleted
NCT04637048
Observational Study on Patients With Hepatobiliary TumorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00387348
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancersupportive_care3terminated
NCT02351765
ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancerstreatment1completed
NCT00579865
Quality Of Life in Patients With Malignant Biliary ObstructionNo drug interventionsNot AvailableNot Availablecompleted
NCT00059865
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancertreatment1 / 2completed
NCT00003427
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancertreatment1completed
NCT04333927
Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder CancerNo drug interventionstreatment2unknown_status
NCT00003276
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancertreatment2completed
NCT04066491
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTCtreatment2 / 3terminated
NCT00660140
Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancertreatment2completed
NCT00033540
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinomatreatment2completed
NCT00896467
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT00004604
Biological Therapy in Treating Patients With Metastatic CancerNo drug interventionstreatment1completed
NCT00262769
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumorstreatment3completed
NCT03637569
The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01317069
A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancertreatment2unknown_status
NCT00003046
Interleukin-12 in Treating Patients With Cancer in the Abdomentreatment1completed
NCT03260712
Pembrolizumab in Biliary Tract Cancertreatment2completed
NCT05489250
The PLATON NetworkNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003923
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreastreatment2completed
NCT06531408
Predicting Incidental Gallbladder CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00414843
Storage of Bile From Routine Procedures to Study Risk FactorsNo drug interventionsNot AvailableNot Availableterminated
NCT06013943
Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBCtreatment2recruiting
NCT03607643
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignanciestreatment1 / 2unknown_status
NCT01151761
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantationtreatment2terminated
NCT03133286
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)No drug interventionsNot AvailableNot Availablecompleted
NCT02867865
Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancerstreatment2 / 3recruiting